The Centers for Disease Control and Prevention raised its official 2026 measles death toll to two on Tuesday as the national case count reached 3,659, while Pennsylvania continued to report four measles-associated deaths from the country’s largest state outbreak.

The difference is not simply a four-versus-two factual dispute. The CDC is now relying on the National Center for Health Statistics to verify deaths in which measles is recorded as the underlying cause, while Pennsylvania uses a broader surveillance definition that counts certain deaths occurring during an active, laboratory-supported infection when an unrelated cause has been excluded. Those approaches can classify the same complex death differently, especially when several medical conditions contributed.

The federal total remains preliminary. The CDC says reviews are continuing and the number may change, but it has not identified where either death occurred. Pennsylvania’s outbreak had reached 903 cases by Monday, including 114 reported during the preceding week, according to the Washington Post. The unresolved gap matters because mortality surveillance is used to describe disease severity, direct public-health resources and communicate risk in an outbreak driven overwhelmingly by infections among people without documented full vaccination.

A national outbreak still accelerating

The CDC’s latest surveillance update counted 3,659 confirmed cases through Sept. 24 across 47 jurisdictions, plus 17 cases among international visitors. Forty outbreaks had been reported during 2026, and 95% of all confirmed cases were outbreak-associated. The national total is already 60% higher than the 2,289 cases recorded for all of 2025 and is the highest annual count since 1991.

The raw national figure is also a lagging measure. States lead case investigations and publish on different schedules; the CDC updates only confirmed cases reported to it by noon each Thursday. State dashboards can therefore be more current, and probable cases may remain outside the federal total until they satisfy the national confirmation process. That timing difference is routine for case surveillance, but a separate change in mortality reporting has made the gap over deaths more consequential.

Federal officials told Reuters that the National Center for Health Statistics received another state report and verified that measles was listed as the underlying cause. The agency had added the first death the prior week through the same process. Neither the state of residence nor the patient’s age, vaccination status or clinical course was disclosed, limiting any comparison with Pennsylvania’s cases.

Why the death counts can diverge

“Underlying cause” has a specific role in vital statistics. The NCHS manual defines it as the disease or injury that initiated the chain of events leading directly or indirectly to death. Death certificates may list an immediate cause, underlying conditions and other contributing illnesses, but national tabulations ordinarily assign one underlying cause to each decedent under international coding rules. A patient can therefore have measles recorded as a contributing condition without measles becoming the underlying cause used in the primary mortality count.

Pennsylvania’s definition answers a somewhat different surveillance question. The state counts a confirmed measles-associated death when death occurs within 30 days of symptom onset, the person has clinical evidence and a positive laboratory test, and the death is not attributable to an unrelated event. Its published criteria also consider exposure history and medical records. The state excludes deaths without laboratory evidence, deaths following full recovery and deaths more than 30 days after rash onset.

Neither framework automatically proves that the other is inaccurate. Pennsylvania’s method is designed to capture deaths temporally and clinically associated with active infection, while the federal method is tied to the certifier’s causal sequence and the coding of a single underlying cause. The distinction is especially important for patients with serious preexisting disease, because measles may have worsened a condition without being coded as the initiating cause, or it may have initiated the fatal chain while other complications appeared more prominently in the clinical record.

The absence of a shared measles-death definition is the central systems problem. The CDC says it is working with the Council of State and Territorial Epidemiologists to create uniform criteria, a process that began before Tuesday’s update. A prior Reuters report noted that the effort followed the federal government’s shift away from relying primarily on state health departments for the national fatality tally. Until that work is complete, state and federal numbers may remain technically defensible yet publicly confusing.

The clinical risk extends beyond mortality

Deaths are the most severe outcome, but they are not the only measure of burden. Pennsylvania had reported 176 hospitalizations by Tuesday, and fewer than 1% of its cases involved people who were fully vaccinated, according to state data cited by the Guardian. Those figures do not establish the individual causes of every hospitalization, and the state’s outbreak population may differ from the country as a whole. They do show that the outbreak has required substantial acute care while remaining concentrated among people without complete vaccine protection.

Measles is one of the most transmissible human infections. The CDC estimates that as many as nine of 10 susceptible people exposed at close range will become infected. Virus-containing particles can remain in indoor air for up to two hours after an infected person leaves, and transmission can occur before the characteristic rash makes the diagnosis obvious. The agency’s clinical summary identifies children younger than 5, adults older than 20, pregnant people and those with weakened immune systems as groups at greater risk for severe complications.

Most patients recover, but pneumonia and encephalitis can occur, and there is no measles-specific antiviral treatment. Care is supportive and directed at complications such as breathing difficulty or dehydration. That clinical reality makes prevention, rapid isolation, laboratory confirmation and contact tracing more important than the small absolute number of deaths might suggest.

Declining vaccine coverage created room for spread

Two doses of the measles, mumps and rubella vaccine are about 97% effective against measles, while one dose is about 93% effective, according to the CDC’s vaccine guidance. No vaccine is perfect, and breakthrough infections can occur after intense exposure or in people whose immune response is weaker. The evidence from this outbreak nevertheless points to susceptibility, not vaccine failure, as the dominant condition enabling sustained transmission.

National kindergarten MMR coverage fell from 95.2% in the 2019-2020 school year to 92.4% in 2025-2026. The CDC estimates that roughly 280,000 kindergartners were at risk during the latest school year. National averages also conceal local clusters: a state can appear close to the population target while individual counties, schools or close-knit communities remain well below the level needed to interrupt transmission.

Coverage above 95% is commonly used as the benchmark for community protection because measles spreads so efficiently. Falling below that threshold does not mean every community will experience an outbreak, and vaccination coverage alone does not determine where an imported case lands. It does increase the number of susceptible contacts available once the virus arrives, making longer chains of transmission more likely.

What stronger surveillance must resolve

A national definition should specify the necessary laboratory evidence, the acceptable interval between infection and death, how to handle recovery, and how underlying conditions affect classification. It should also distinguish clearly between deaths caused by measles, deaths to which measles contributed and deaths that merely occurred after infection. Publishing those categories separately could preserve clinical nuance without forcing unlike records into a single number.

Timeliness presents another tradeoff. State epidemiologists can classify deaths quickly using outbreak investigations and medical records, while the vital-statistics system emphasizes standardized coding that may take longer. A two-stage process—provisional outbreak reporting followed by finalized mortality coding—could communicate both speed and certainty, provided revisions are visible and definitions remain stable.

The CDC’s second confirmed death establishes that the 2026 outbreak has produced fatal disease under the federal government’s strict underlying-cause standard. Pennsylvania’s four associated deaths describe a broader but explicitly defined measure. The immediate public-health conclusion does not depend on resolving the difference: thousands of confirmed infections, 176 hospitalizations in the hardest-hit state and vaccine coverage below the national protection target show that measles has regained space to spread. The next test is whether federal and state officials can produce a common mortality framework quickly enough to restore clarity while the outbreak is still expanding.